ロード中...
Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy
Several mood-stabilizing atypical antipsychotics and antidepressants weakly block serotonin (5-HT) receptor type-7 (5-HT7R); however, the contributions of 5-HT7R antagonism to clinical efficacy and pathophysiology are yet to be clarified. A novel mood-stabilizing antipsychotic agent, lurasidone exhi...
保存先:
| 出版年: | Front Psychiatry |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7930824/ https://ncbi.nlm.nih.gov/pubmed/33679481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2021.623684 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|